Sterling Pharma Solutions: API facility acquisition
Contract Development and manufacturing organization (CDMO) Sterling Pharma Solutions has purchased Alcami’s facility in Germantown, Wisconsin. The acquired facility is intended to bolster Sterling’s presence in the US, and to provide additional capacity for customer active pharmaceutical ingredient (API) development and manufacturing.
Kevin Cook, CEO, said, “This is the latest step of our strategic growth plans and will ensure we continue to provide a strong transatlantic API presence to support our customers. The US market continues to be a key growth area for us; in addition to bolstering our API clinical and commercial manufacturing the Germantown facility has extensive expertise in handling high potency APIs, which will be a valuable addition to our organization.”
